Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867008 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT01867008 is a NA study that has completed, run by Cochlear. The registered enrollment target is 55 participants.
The verdict
NCT01867008, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Clinical study to evaluate the safety and efficacy of the Cochlear™ Nucleus® CI422 cochlear implant for new cochlear implant adult recipients with broader requirements to be considered an eligible candidate.
Interventions
- DEVICE Nucleus CI422 Cochlear Implant with N6 Sound Processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01867008
The ClinicalTrials.gov registry entry for NCT01867008 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nucleus CI422 Cochlear Implant with N6 Sound Processor is the first listed.
NCT01867008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01867008 about?
NCT01867008 is a clinical study titled "Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults". Clinical study to evaluate the safety and efficacy of the Cochlear™ Nucleus® CI422 cochlear implant for new cochlear implant adult recipients with broader requirements to be considered an eligible candidate.
What is the current status of trial NCT01867008?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2013-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01867008?
The interventions under investigation include: Nucleus CI422 Cochlear Implant with N6 Sound Processor (DEVICE).
Who is sponsoring clinical trial NCT01867008?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.